摘要
慢性阻塞性肺疾病是一种常见的、可防可治的慢性呼吸系统疾病,其高发病率、高致残率、高死亡率让其成为世界范围内的重大公共卫生难题。慢性阻塞性肺疾病全球创议科学委员会组织了一次论坛,就慢性阻塞性肺疾病诊治领域内的有争议的话题进行了讨论:诊断与评估、疾病发生危险因素、稳定期患者治疗进展及急性加重期的评估与治疗。文章就讨论内容的临床运用做一解读。
Chronic obstructive pulmonary disease(COPD) is a preventable and treatable disease with high rate of incidence, disability,and mortality, making COPD a heavy burden worldwide. The Global Initiative for Chronic Obstructive Lung Disease Scientific Committee organized a forum and discussed some controversial topics in COPD, including: diagnosis and assessment;risk factors for disease development, advances in treatment of the stable patient, and the assessment and treatment of exacerbations. This article interprets clinical utility of these contents.
作者
申永春
陈磊
文富强
SHEN Yong-chun;CHEN Lei;WEN Fu-qiang(Department of Respiratory Medicine, West China Hospital of Sichuan University, Division of Pulmonary Diseases, State KeyLaboratory of Biotherapy of China, Chengdu 610041, China)
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2019年第5期425-430,共6页
Chinese Journal of Practical Internal Medicine
基金
国家重点研发计划(2016YFC0903600
2016YFC1304500)
自然科学基金面上项目(31871157)
关键词
慢性阻塞性肺疾病
评估
治疗
chronic obstructive pulmonary disease
evaluation
treatment